The Miriad product line offers researchers a number of advantages over other rapid test tools currently available to them, including speed, quality and multiple testing on a single cartridge.
Miriad includes multiple rapid tests and developer tools to facilitate vaccine and drug development, clinical trials, tissue bank screening, educational outcomes, and new rapid test development. The product line offers fully commercialized rapid combination tests for Hepatitis B and C, HIV, and Syphilis. Miriad enables academic, medical and clinical researchers to use rapid tests built on the same technology as MedMira’s FDA-approved rapid HIV test, Reveal G3.
Miriad also includes an off-the-shelf Developer Toolkit which contains all the key components necessary to create unique rapid flow-through tests. The researcher need only provide the capture protein of interest and the specimen containing the targeted analyte. Scientists can now benefit from and build upon a mature, proven technology that has resulted from MedMira’s research and development work.
